-
Je něco špatně v tomto záznamu ?
Liver macrophages regulate systemic metabolism through non-inflammatory factors
C. Morgantini, J. Jager, X. Li, L. Levi, V. Azzimato, A. Sulen, E. Barreby, C. Xu, M. Tencerova, E. Näslund, C. Kumar, F. Verdeguer, S. Straniero, K. Hultenby, NK. Björkström, E. Ellis, M. Rydén, C. Kutter, T. Hurrell, VM. Lauschke, J. Boucher,...
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
32694874
DOI
10.1038/s42255-019-0044-9
Knihovny.cz E-zdroje
- MeSH
- játra metabolismus MeSH
- lidé MeSH
- makrofágy metabolismus MeSH
- myši MeSH
- obezita metabolismus MeSH
- proteiny vázající insulinu podobné růstové faktory genetika MeSH
- zánět metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Liver macrophages (LMs) have been proposed to contribute to metabolic disease through secretion of inflammatory cytokines. However, anti-inflammatory drugs lead to only modest improvements in systemic metabolism. Here we show that LMs do not undergo a proinflammatory phenotypic switch in obesity-induced insulin resistance in flies, mice and humans. Instead, we find that LMs produce non-inflammatory factors, such as insulin-like growth factor-binding protein 7 (IGFBP7), that directly regulate liver metabolism. IGFBP7 binds to the insulin receptor and induces lipogenesis and gluconeogenesis via activation of extracellular-signal-regulated kinase (ERK) signalling. We further show that IGFBP7 is subject to RNA editing at a higher frequency in insulin-resistant than in insulin-sensitive obese patients (90% versus 30%, respectively), resulting in an IGFBP7 isoform with potentially higher capacity to bind to the insulin receptor. Our study demonstrates that LMs can contribute to insulin resistance independently of their inflammatory status and indicates that non-inflammatory factors produced by macrophages might represent new drug targets for the treatment of metabolic diseases.
Bioscience Cardiovascular Renal and Metabolism IMED Biotech Unit AstraZeneca Gothenburg Sweden
Department of Laboratory Medicine Clinical Research Center Karolinska Institutet Huddinge Sweden
Department of Molecular Mechanisms of Disease University of Zurich Zurich Switzerland
Division of Transplantation Surgery CLINTEC Karolinska Institutet Huddinge Sweden
Integrated Cardio Metabolic Center Department of Medicine Karolinska Institutet Huddinge Sweden
Unit of Endocrinology Department of Medicine Karolinska Institutet Huddinge Sweden
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21013016
- 003
- CZ-PrNML
- 005
- 20210713112310.0
- 007
- ta
- 008
- 210420s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s42255-019-0044-9 $2 doi
- 035 __
- $a (PubMed)32694874
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Morgantini, Cecilia $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 245 10
- $a Liver macrophages regulate systemic metabolism through non-inflammatory factors / $c C. Morgantini, J. Jager, X. Li, L. Levi, V. Azzimato, A. Sulen, E. Barreby, C. Xu, M. Tencerova, E. Näslund, C. Kumar, F. Verdeguer, S. Straniero, K. Hultenby, NK. Björkström, E. Ellis, M. Rydén, C. Kutter, T. Hurrell, VM. Lauschke, J. Boucher, A. Tomčala, G. Krejčová, A. Bajgar, M. Aouadi
- 520 9_
- $a Liver macrophages (LMs) have been proposed to contribute to metabolic disease through secretion of inflammatory cytokines. However, anti-inflammatory drugs lead to only modest improvements in systemic metabolism. Here we show that LMs do not undergo a proinflammatory phenotypic switch in obesity-induced insulin resistance in flies, mice and humans. Instead, we find that LMs produce non-inflammatory factors, such as insulin-like growth factor-binding protein 7 (IGFBP7), that directly regulate liver metabolism. IGFBP7 binds to the insulin receptor and induces lipogenesis and gluconeogenesis via activation of extracellular-signal-regulated kinase (ERK) signalling. We further show that IGFBP7 is subject to RNA editing at a higher frequency in insulin-resistant than in insulin-sensitive obese patients (90% versus 30%, respectively), resulting in an IGFBP7 isoform with potentially higher capacity to bind to the insulin receptor. Our study demonstrates that LMs can contribute to insulin resistance independently of their inflammatory status and indicates that non-inflammatory factors produced by macrophages might represent new drug targets for the treatment of metabolic diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x metabolismus $7 D007249
- 650 _2
- $a proteiny vázající insulinu podobné růstové faktory $x genetika $7 D018969
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a makrofágy $x metabolismus $7 D008264
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a obezita $x metabolismus $7 D009765
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jager, Jennifer $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden ; Université Nice Côte d'Azur, INSERM U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity, Nice, France
- 700 1_
- $a Li, Xidan $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Levi, Laura $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Azzimato, Valerio $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Sulen, André $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Barreby, Emelie $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Xu, Connie $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Tencerova, Michaela $u Department of Molecular Endocrinology, KMEB, University of Southern Denmark, Odense University Hospital and Danish Diabetes Academy, Odense, Denmark
- 700 1_
- $a Näslund, Erik $u Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Kumar, Chanchal $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden ; Translational Sciences, Cardiovascular, Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
- 700 1_
- $a Verdeguer, Francisco $u Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Straniero, Sara $u Metabolism Unit C2:94, Department of Medicine, and Center for Innovative Medicine, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm, Sweden
- 700 1_
- $a Hultenby, Kjell $u Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Björkström, Niklas K $u Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Ellis, Ewa $u Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Rydén, Mikael $u Unit of Endocrinology, Department of Medicine, Karolinska Institutet, Huddinge, Sweden
- 700 1_
- $a Kutter, Claudia $u Department of Microbiology, Tumor and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Hurrell, Tracey $u Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden
- 700 1_
- $a Lauschke, Volker M $u Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden
- 700 1_
- $a Boucher, Jeremie $u Bioscience, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden $u Wallenberg Centre for Molecular and Translational Medicine, Lundberg Laboratory for Diabetes Research, University of Gothenburg, Gothenburg, Sweden
- 700 1_
- $a Tomčala, Aleš $u Laboratory of Evolutionary Protistology, Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Ceske Budejovice, Czech Republic
- 700 1_
- $a Krejčová, Gabriela $u Faculty of Science, University of South Bohemia, and Institute of Entomology, Biology Centre, Czech Academy of Sciences, Ceske Budejovice, Czech Republic
- 700 1_
- $a Bajgar, Adam $u Faculty of Science, University of South Bohemia, and Institute of Entomology, Biology Centre, Czech Academy of Sciences, Ceske Budejovice, Czech Republic
- 700 1_
- $a Aouadi, Myriam $u Integrated Cardio Metabolic Center (ICMC), Department of Medicine, Karolinska Institutet, Huddinge, Sweden. myriam.aouadi@ki.se
- 773 0_
- $w MED00207066 $t Nature metabolism $x 2522-5812 $g Roč. 1, č. 4 (2019), s. 445-459
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32694874 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210713112307 $b ABA008
- 999 __
- $a ok $b bmc $g 1651245 $s 1133395
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 1 $c 4 $d 445-459 $e 20190325 $i 2522-5812 $m Nature metabolism $n Nat Metab $x MED00207066
- LZP __
- $a Pubmed-20210420